Accounts Payable, Current of BIO-RAD LABORATORIES, INC. from 31 Dec 2010 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
- Summary
-
BIO-RAD LABORATORIES, INC. quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
- BIO-RAD LABORATORIES, INC. Accounts Payable, Current for the quarter ending 31 Dec 2025 was $129,000,000, a 5.5% increase year-over-year.
- Source SEC data
- View on sec.gov
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)
BIO-RAD LABORATORIES, INC. Quarterly Accounts Payable, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $129,000,000 | +$6,700,000 | +5.5% | 31 Dec 2025 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q3 2025 | $128,800,000 | +$6,615,000 | +5.4% | 30 Sep 2025 | 10-Q | 29 Oct 2025 | 2025 | Q3 |
| Q2 2025 | $139,300,000 | +$12,607,000 | +10% | 30 Jun 2025 | 10-Q | 31 Jul 2025 | 2025 | Q2 |
| Q1 2025 | $137,900,000 | +$35,150,000 | +34% | 31 Mar 2025 | 10-Q | 01 May 2025 | 2025 | Q1 |
| Q4 2024 | $122,300,000 | -$22,300,000 | -15% | 31 Dec 2024 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q3 2024 | $122,185,000 | +$10,326,000 | +9.2% | 30 Sep 2024 | 10-Q | 31 Oct 2024 | 2024 | Q3 |
| Q2 2024 | $126,693,000 | -$22,842,000 | -15% | 30 Jun 2024 | 10-Q | 02 Aug 2024 | 2024 | Q2 |
| Q1 2024 | $102,750,000 | -$58,229,000 | -36% | 31 Mar 2024 | 10-Q | 08 May 2024 | 2024 | Q1 |
| Q4 2023 | $144,600,000 | +$9,559,000 | +7.1% | 31 Dec 2023 | 10-K | 14 Feb 2025 | 2024 | FY |
| Q3 2023 | $111,859,000 | -$30,887,000 | -22% | 30 Sep 2023 | 10-Q | 27 Oct 2023 | 2023 | Q3 |
| Q2 2023 | $149,535,000 | -$8,724,000 | -5.5% | 30 Jun 2023 | 10-Q | 04 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $160,979,000 | +$328,000 | +0.2% | 31 Mar 2023 | 10-Q | 05 May 2023 | 2023 | Q1 |
| Q4 2022 | $135,041,000 | -$6,900,000 | -4.9% | 31 Dec 2022 | 10-K | 16 Feb 2024 | 2023 | FY |
| Q3 2022 | $142,746,000 | +$6,348,000 | +4.7% | 30 Sep 2022 | 10-Q | 28 Oct 2022 | 2022 | Q3 |
| Q2 2022 | $158,259,000 | +$24,802,000 | +19% | 30 Jun 2022 | 10-Q | 29 Jul 2022 | 2022 | Q2 |
| Q1 2022 | $160,651,000 | +$22,157,000 | +16% | 31 Mar 2022 | 10-Q | 29 Apr 2022 | 2022 | Q1 |
| Q4 2021 | $141,941,000 | +$2,490,000 | +1.8% | 31 Dec 2021 | 10-K | 17 Feb 2023 | 2022 | FY |
| Q3 2021 | $136,398,000 | +$3,404,000 | +2.6% | 30 Sep 2021 | 10-Q | 29 Oct 2021 | 2021 | Q3 |
| Q2 2021 | $133,457,000 | 30 Jun 2021 | 10-Q | 30 Jul 2021 | 2021 | Q2 | ||
| Q1 2021 | $138,494,000 | 31 Mar 2021 | 10-Q | 30 Apr 2021 | 2021 | Q1 | ||
| Q4 2020 | $139,451,000 | +$32,437,000 | +30% | 31 Dec 2020 | 10-K | 11 Feb 2022 | 2021 | FY |
| Q3 2020 | $132,994,000 | 30 Sep 2020 | 10-Q | 30 Oct 2020 | 2020 | Q3 | ||
| Q4 2019 | $107,014,000 | -$15,436,000 | -13% | 31 Dec 2019 | 10-K | 16 Feb 2021 | 2020 | FY |
| Q4 2018 | $122,450,000 | -$12,732,000 | -9.4% | 31 Dec 2018 | 10-K | 02 Mar 2020 | 2019 | FY |
| Q4 2017 | $135,182,000 | +$2,073,000 | +1.6% | 31 Dec 2017 | 10-K | 01 Apr 2019 | 2018 | FY |
| Q4 2016 | $133,109,000 | +$10,718,000 | +8.8% | 31 Dec 2016 | 10-K | 16 Apr 2018 | 2017 | FY |
| Q4 2015 | $122,391,000 | -$6,217,000 | -4.8% | 31 Dec 2015 | 10-K | 01 Mar 2017 | 2016 | FY |
| Q4 2014 | $128,608,000 | -$19,902,000 | -13% | 31 Dec 2014 | 10-K | 29 Feb 2016 | 2015 | FY |
| Q3 2014 | $126,640,000 | -$5,259,000 | -4% | 30 Sep 2014 | 10-Q | 07 Nov 2014 | 2014 | Q3 |
| Q2 2014 | $125,461,000 | -$3,658,000 | -2.8% | 30 Jun 2014 | 10-Q | 06 Aug 2014 | 2014 | Q2 |
| Q1 2014 | $130,864,000 | +$11,524,000 | +9.7% | 31 Mar 2014 | 10-Q | 08 May 2014 | 2014 | Q1 |
| Q4 2013 | $148,510,000 | +$17,643,000 | +13% | 31 Dec 2013 | 10-K | 02 Mar 2015 | 2014 | FY |
| Q3 2013 | $131,899,000 | +$18,617,000 | +16% | 30 Sep 2013 | 10-Q | 12 Nov 2013 | 2013 | Q3 |
| Q2 2013 | $129,119,000 | +$9,671,000 | +8.1% | 30 Jun 2013 | 10-Q | 08 Aug 2013 | 2013 | Q2 |
| Q1 2013 | $119,340,000 | +$9,769,000 | +8.9% | 31 Mar 2013 | 10-Q | 10 May 2013 | 2013 | Q1 |
| Q4 2012 | $130,867,000 | +$1,743,000 | +1.4% | 31 Dec 2012 | 10-K | 18 Mar 2014 | 2013 | FY |
| Q3 2012 | $113,282,000 | -$194,000 | -0.17% | 30 Sep 2012 | 10-Q | 08 Nov 2012 | 2012 | Q3 |
| Q2 2012 | $119,448,000 | -$1,066,000 | -0.88% | 30 Jun 2012 | 10-Q | 09 Aug 2012 | 2012 | Q2 |
| Q1 2012 | $109,571,000 | 31 Mar 2012 | 10-Q | 10 May 2012 | 2012 | Q1 | ||
| Q4 2011 | $129,124,000 | +$15,684,000 | +14% | 31 Dec 2011 | 10-K | 18 Mar 2013 | 2012 | FY |
| Q3 2011 | $113,476,000 | 30 Sep 2011 | 10-Q | 03 Nov 2011 | 2011 | Q3 | ||
| Q2 2011 | $120,514,000 | 30 Jun 2011 | 10-Q | 04 Aug 2011 | 2011 | Q2 | ||
| Q4 2010 | $113,440,000 | 31 Dec 2010 | 10-K | 29 Feb 2012 | 2011 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.